Strategic advice from experts you trust

Weekly Gist

Welcome to the Weekly Gist, where we distill the latest healthcare news, trends and our conversations with industry leaders into actionable guidance for CEOs and senior executives.

For more insights like these, subscribe to the Weekly Gist and receive an executive-level analysis of the week’s news delivered your inbox every Friday.

The Weekly Gist: The Cats Versus Birds Edition

As the US enters a third wave of the pandemic, the FDA grants full approval of a COVID therapy for the first time. Meanwhile, a new survey suggests that Americans are growing more skeptical of a possible coronavirus vaccine.
Read More

The Weekly Gist: The “Who Was That Unmasked Man?” Edition

President Trump's recent illness spotlights the availability of new therapeutics to fight COVID-19, as the vaccine timeline lengthens. Meanwhile, Walmart takes a big step into the Medicare business.
Read More

The Weekly Gist: The Renegade Civics Lesson Edition

Concerns about political interference at the CDC mount, forcing officials to reverse controversial guidance on COVID testing. Meanwhile, HHS withdraws an unpopular change to Medicaid payment policies.
Read More

The Weekly Gist: The Christmas in Manila Edition

With US virus deaths now predicted to more than double by year's end, clinical trials of a leading vaccine candidate are put on hold, and leading drug developers pledge to prioritize safety and efficacy.
Read More

The Weekly Gist: The Great Worm Escape Edition

Testing and therapeutics controversies flared up at the CDC and FDA, as Republicans gathered for their convention. Meanwhile, a new rapid COVID test promised to provide a solution to the nation's testing woes.
Read More